June 27th 2025. The unfortunate news of President Biden’s diagnosis has put a spotlight on prostate cancer, offering an opportunity to educate on the risks of the disease and the benefits of screening ...

The bladder cancer section is a comprehensive resource for urology news and expert insights. Read more at Urology Times.

June 25th 2025. Oral sulopenem was approved by the FDA in October 2024 for the management of uUTIs.

Former President Joseph R. Biden’s recent diagnosis of metastatic prostate cancer has put prostate health back into the national spotlight. His courage in sharing his diagnosis, particularly at age 82 ...

First-line nivolumab (Opdivo) plus ipilimumab (Yervoy) continued to show improved survival and durable response benefits vs sunitinib (Sutent) in patients with previously untreated advanced renal cell ...

Results of subgroup analyses of the phase 3 CREST trial (NCT04165317) evaluating sasanlimab plus BCG compared with BCG alone in patients with high-risk non–muscle invasive bladder cancer (NMIBC) found ...

The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted in a unanimous 0-8 decision that the TALAPRO-2 data on talazoparib (Talzenna) in combination with enzalutamide (Xtandi) is not sufficient to ...

The ODAC meeting was called to discuss the submitted new drug application (NDA) for UGN-102, which the agency previously accepted in October 2024, issuing a Prescription Drug User Fee Act (PDUFA) ...

Landmark randomized trials conducted in the early 2000s demonstrated a survival advantage for up-front cytoreductive surgery in combination with interferon alfa compared with interferon alpha alone, ...

Data from the AUSCO trial (NCT04088331) were presented at the 2025 American Urological Association Annual Meeting in Las Vegas, Nevada, showing that the artificial urinary sphincter (AUS) demonstrated ...

A recent study examined the relationship between randomized controlled trials and real-world efficacy of prostate cancer treatments. 1 Investigators found that benefits of treatments that are observed ...

“I think the best thing about these guidelines is their actual existence,” says Karyn S. Eilber, MD. One of many notable highlights from the 2025 American Urological Association Annual Meeting in Las ...